BRIEF-Novo Nordisk says data shows early response to Saxenda resulted in improvements in weight loss

June 2, 2016 4:18 PM

10 0

* Says people treated with Saxenda who lost 5 percent or more of their body weight at 16 weeks, classified as "early responders", demonstrated greater weight loss and improvements in cardiometabolic risk factors at week 160 compared with those who lost less than 5 pct of their body weight at 16 weeks, "early non-responders"

* Says at week 160, Saxenda early responders who completed the trial achieved an average weight loss of 8.6 pct (9.1 kg), compared with 2.9 (3.1 kg) in early non-responders.

Read more

To category page